1. Home
  2. KFRC vs VNDA Comparison

KFRC vs VNDA Comparison

Compare KFRC & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kforce Inc.

KFRC

Kforce Inc.

HOLD

Current Price

$43.31

Market Cap

499.7M

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$7.53

Market Cap

411.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KFRC
VNDA
Founded
1962
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
499.7M
411.3M
IPO Year
1996
2005

Fundamental Metrics

Financial Performance
Metric
KFRC
VNDA
Price
$43.31
$7.53
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$39.67
$14.90
AVG Volume (30 Days)
322.3K
1.0M
Earning Date
04-27-2026
05-06-2026
Dividend Yield
3.42%
N/A
EPS Growth
N/A
N/A
EPS
0.46
N/A
Revenue
$1,329,007,000.00
$216,105,000.00
Revenue This Year
$2.78
$21.35
Revenue Next Year
$4.32
$37.40
P/E Ratio
$96.28
N/A
Revenue Growth
N/A
8.72
52 Week Low
$24.49
$3.81
52 Week High
$47.50
$9.91

Technical Indicators

Market Signals
Indicator
KFRC
VNDA
Relative Strength Index (RSI) 70.86 57.39
Support Level $26.60 $7.12
Resistance Level $47.48 $7.79
Average True Range (ATR) 2.12 0.28
MACD 1.33 0.07
Stochastic Oscillator 75.82 98.99

Price Performance

Historical Comparison
KFRC
VNDA

About KFRC Kforce Inc.

Kforce Inc is a solutions firm specializing in technology, finance, accounting, and other professional staffing services. The company operates two business segments: the Technology segment, which provides talent solutions with candidates skilled in areas including systems/applications architecture and development, data management and analytics, business and artificial intelligence, machine learning, project and program management, and network architecture and security. The FA segment offers consultants in traditional finance and accounting roles such as finance, planning and analysis; business intelligence analysis; general accounting; transactional accounting, business and cost analysis; and taxation and treasury. The majority of revenue is earned through the Technology segment.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: